Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

3.8K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Activation of Integrins01:15

Activation of Integrins

5.4K
Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.4K
Integrins01:10

Integrins

5.9K
Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

15.6K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
15.6K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

6.6K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development of a Nanoscale Protein-Protein Mapping of PDE4 Interface-Disrupting Peptides.

Nano letters·2026
Same author

A modular hydrogel system with independent control of bioadhesion, fibrosis, and stiffness.

Science advances·2026
Same author

The Use of Deep Learning in RNA Therapeutic Development.

ACS nano·2026
Same author

Wireless battery-free oxygenation devices enable extended immunosuppression-free islet transplantation in minimally invasive sites.

Device·2026
Same author

The long noncoding RNA <i>lnc-FAM164A1</i>-ACLY axis promotes pro-inflammatory responses in human primary macrophages: a systems approach.

Frontiers in immunology·2026
Same author

Tuning the immune response to mRNA vaccines.

Nature biotechnology·2026

Related Experiment Video

Updated: Mar 15, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K

Interaction between integrin α5 and PDE4D regulates endothelial inflammatory signalling.

Sanguk Yun1, Madhusudhan Budatha1, James E Dahlman2,3,4

  • 1Department of Internal Medicine, Yale Cardiovascular Research Center, Yale University, New Haven, Connecticut 06520, USA.

Nature Cell Biology
|September 6, 2016
PubMed
Summary

Researchers found that fibronectin in the arterial extracellular matrix (ECM) promotes inflammation by increasing phosphodiesterase (PDE) activity, which lowers anti-inflammatory cAMP levels. Targeting PDE4D5 could offer new atherosclerosis therapies.

More Related Videos

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
12:55

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation

Published on: December 9, 2021

4.0K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.4K

Related Experiment Videos

Last Updated: Mar 15, 2026

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
12:50

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response

Published on: September 15, 2017

7.0K
A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation
12:55

A Microphysiological System to Study Leukocyte-Endothelial Cell Interaction during Inflammation

Published on: December 9, 2021

4.0K
On-Chip Endothelial Inflammatory Phenotyping
12:43

On-Chip Endothelial Inflammatory Phenotyping

Published on: July 21, 2012

11.4K

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Extracellular Matrix Biology

Background:

  • Atherosclerosis involves lipid metabolism, inflammation, and extracellular matrix (ECM) remodeling.
  • Fibronectin accumulation in the arterial basement membrane is linked to endothelial inflammation.

Purpose of the Study:

  • To investigate the mechanism by which fibronectin modulates arterial inflammation.
  • To identify molecular targets for mitigating fibronectin-driven inflammation.

Main Methods:

  • Engineered endothelial cells with a chimeric integrin receptor (α5/α2).
  • Utilized knock-in mouse models with the chimeric integrin.
  • Assessed inflammatory signaling, cyclic AMP (cAMP) levels, and phosphodiesterase (PDE) activity.
  • Investigated the interaction between integrin α5 and PDE4D5.

Main Results:

  • The chimeric integrin suppressed inflammatory signaling in endothelial cells and in vivo.
  • Fibronectin reduced anti-inflammatory cAMP by enhancing PDE activity.
  • Integrin α5 directly bound to PDE4D5, promoting its dephosphorylation and activity.
  • Knockdown of PDE4D5 reduced inflammation in athero-prone sites in mice.

Conclusions:

  • Fibronectin promotes arterial inflammation by enhancing PDE4D5 activity, leading to suppressed cAMP.
  • The interaction between integrin α5 and PDE4D5 is a key mechanism linking ECM remodeling to inflammation.
  • Targeting the integrin α5-PDE4D5 pathway represents a novel therapeutic strategy for atherosclerosis.